Results 211 to 220 of about 177,584 (349)
The advent of aptamers has highlighted their potential as alternatives to antibodies, overcoming limitations of structural instability and production cost. However, conventional approaches such as SELEX remain slow and labor‐intensive. This review examines recent advances in aptamer engineering, emphasizing in vitro and AI‐driven in silico strategies ...
John V. L. Nguyen +5 more
wiley +1 more source
Exploring exosomal lncRNAs: unlocking the molecular code of tumor metastasis and drug resistance. [PDF]
Zhang R, Li M, Lu S, Wang A, Zhang S.
europepmc +1 more source
Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies [PDF]
Amirata Mohseni +11 more
openalex +1 more source
Exosome-dependent Trafficking of HSP70 [PDF]
Graeme I. Lancaster, Mark A. Febbraio
openalex +1 more source
Molecularly imprinted polymeric nanocarriers (nanoMIPs) offer robust, antibody‐mimetic platforms to overcome the blood‐brain barrier. The article surveys nanoMIP design and ligand‐directed surface engineering that harness receptor‐mediated transcytosis, and highlights therapeutic and diagnostic applications in neurodegeneration, brain tumors and ...
Ranjit De, Shuliang Shi, Kyong‐Tai Kim
wiley +1 more source
A multifunctional vascular bed platform is created using coaxial 3D printing, allowing the one‐step integration of organoid microspheres with perfusable vascular structures. This strategy enables rapid and functional vascularization of organoids to support tissue repair and vascularization, providing a scalable and translationally promising approach ...
Kunrui Wang +10 more
wiley +1 more source
Anti-Inflammatory and Skin-Lightening Activities of Exosomes Derived from <i>Latilactobacillus sakei</i> BK-5 Isolated from <i>Aster koraiensis</i> Flowers. [PDF]
Lee CY +6 more
europepmc +1 more source
Exosome-Induced Regulation in Inflammatory Bowel Disease [PDF]
Huiting Zhang +6 more
openalex +1 more source
CD147/Basigin: From Integrative Molecular Hub to Translational Therapeutic Target
This review conceptualizes CD147 as a fundamental “Energy‐Structure Coupler,” physically bridging metabolic flux (via MCTs) with morphogenetic plasticity (via integrins/MMPs) to drive cancer, infection, and autoimmunity. Addressing the “specificity paradox” that limits current translation, the authors chart a strategic roadmap—spanning logic‐gated ...
Xiang‐Min Yang +2 more
wiley +1 more source
Exosomal proteomics reveals fatty acid metabolism linked to gefitinib resistance in non-small cell lung cancer. [PDF]
Zhang Y, Zhu W, Zhu J, Hu R, Yang Y.
europepmc +1 more source

